Consolidated Financial Results

for the Three Months Ended March 31, 2021

[Japanese GAAP]

May 6, 2021

Company name: GMO Pepabo, Inc.

Stock exchange listing: Tokyo Stock Exchange

Code number: 3633

URL: https://pepabo.com/

Representative: Kentaro Sato, CEO and President

Contact: Yoshito Igashima, CFO and Board Director

Phone: +81-3-5456-3021

Scheduled date of filing quarterly securities report: May 12, 2021

Scheduled date of commencing dividend payments: ―

Availability of supplementary briefing material on quarterly financial results: Available

Schedule of quarterly financial results briefing session: Scheduled (for institutional investors and analysts)

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Three Months Ended March 31, 2021 (from January 1, 2021 to March 31, 2021)

(1) Consolidated Operating Results

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Three months ended

Million yen

%

Million yen

%

Million yen

%

Million yen

%

March 31, 2021

2,911

21.4

234

20.8

233

(3.0)

185

43.8

March 31, 2020

2,398

9.7

194

(35.2)

240

(22.1)

128

(47.5)

(Note) Comprehensive income: Three months ended March 31, 2021: ¥237 million [99.8%] Three months ended March 31, 2020: ¥118 million [(53.4)%]

Basic earnings

Diluted earnings

per share

per share

Three months ended

Yen

Yen

March 31, 2021

35.09

34.82

March 31, 2020

24.72

24.71

(2) Consolidated Financial Position

Total assets

Net assets

Equity ratio

Million yen

Million yen

%

As of March 31,

2021

7,979

2,372

29.4

As of December

31, 2020

8,211

2,544

30.6

(Reference) Equity: As of March 31, 2021: ¥2,348 million As of December 31, 2020: ¥2,515 million

1

2. Dividends

Annual dividends

1st

2nd

3rd

Year-end

Total

quarter-end

quarter-end

quarter-end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended December 31,

0.00

0.00

0.00

81.00

81.00

2020

Fiscal year ending December 31,

0.00

2021

Fiscal year ending December 31,

0.00

0.00

81.00

81.00

2021 (Forecast)

(Note) Revision to the dividends forecast most recently

announced: No

3. Consolidated Financial Results Forecast for the Fiscal Year Ending December 31, 2021 (from January 1, 2021 to December 31, 2021)

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable

Basic earnings

to owners of parent

per share

First half

Million yen

%

Million yen

%

Million yen

%

Million yen

%

Yen

-

-

-

-

-

-

-

-

-

(cumulative)

Full year

13,223

20.1

1,114

20.2

1,127

14.6

795

(4.2)

150.65

(Note) Revision to the financial results forecast most recently announced: No

2

* Notes:

  1. Changes in significant subsidiaries during the three months ended March 31, 2021: No (Changes in specified subsidiaries resulting in changes in scope of consolidation) New: None
    Excluded: None
  2. Adoption of special accounting methods in preparation of quarterly consolidated financial statements: No
  3. Changes in accounting policies, changes in accounting estimates and retrospective restatement
    1. Changes in accounting policies due to the revision of accounting standards: No
    2. Changes in accounting policies other than 1) above: No
    3. Changes in accounting estimates: No
    4. Retrospective restatement: No
  4. Total number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury stock):

March 31, 2021: 5,468,700 shares

December 31, 2020: 5,468,700 shares

  1. Total number of treasury stock at the end of the period: March 31, 2021: 181,288 shares
    December 31, 2020: 191,288 shares
  2. Average number of shares during the period:

Three months ended March 31, 2021: 5,281,221 shares

Three months ended March 31, 2020: 5,213,394 shares

  • These quarterly financial results are outside the scope of quarterly review by certified public accountants or audit firms.
  • Explanation of the proper use of financial results forecast and other notes

The statements concerning future performance presented in this document are based on currently available information and certain preconditions which the Company believes to be reasonable at this time and does not constitute a guarantee of the Company to achieve. Actual results may be substantially different from these forecasts presented herein due to various factors.

3

Attachments

  • Original document
  • Permalink

Disclaimer

GMO Pepabo Inc. published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2021 18:20:01 UTC.